Per a commemorar aquesta diada l’IDIBELL i l’ICO han fet un vídeo per recordar algunes personalitats històriques del món de la ciència i la medicina que han estat pioneres en la lluita per a la igualtat de gènere i la diversitat. . Dia per l’Alliberament LGBTI La diada a Catalunya
Orgull en ciència: L’IDIBELL s’adhereix a la celebració del Dia per l’Alliberament LGTB+ Read More »
The distinction was granted during the 9th ICS Research Day, which focused on respiratory diseases Xavier Matias-Guiu
Dr. Xavier Matias-Guiu receives an ICS award for his research career Read More »
Researchers from the Rehabilitation and Physiotherapy Department of Bellvitge University Hospital – Bellvitge Biomedical Research Institute (HUB-IDIBELL) have been awarded the VI basic research in physiotherapy grant from the Catalan-Balearic Physiotherapy Society, which will allow them to partially fund the clinical validation of a imaging software prototype designed as a facial neuromuscular therapy in patients
A research team from the Bellvitge Biomedical Research Institute (IDIBELL) has managed to characterize the complete epigenomes of the most frequent tumors, including those of colon, lung and breast cancer. Their work, published in Oncogene, was led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor
The complete epigenomes of the most frequent tumors, unveiled Read More »
The four-year project will finance 15 early stage researchers to explain the relationship between cancer, metabolism and the immune system
IDIBELL leads a new European Innovative Training Network Read More »
Dr. Gabriel Capellá presents the hereditary cáncer-related projects of IDIBELL at the XI AECC Symposium
Scientists identify new predisposing genes and microRNAS involved in hereditary cancer Read More »
The Center of Regenerative Medicine in Barcelona (CMR[B]) – currently located within the Barcelona Biomedical Research Park (PRBB) – and the Bellvitge Biomedical Research Institute (IDIBELL) have joined efforts to create the new Regenerative Medicine Program of Catalonia (P-CMR[C]).
IDIBELL and CMRB launch a new Catalan Regenerative Medicine Program Read More »
Researchers from the Cell death group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Cristina Muñoz-Pinedo, have characterized the cell death process due to starvation, in which the endoplasmic reticulum plays a leading role. Their work, chosen as the cover of the latest Molecular and Cellular Biology journal, was carried out within TRAIN-ERs,
Starvation causes atypical cell death Read More »
April 29th, at 6pm Health Day blood donation campaign free invitation for RCDE – Valencia Mejor sin Cáncer Public Health Agency, the Blood and Tissue Bank, the Red Cross, the Spanish Association against Cancer, IDIBELL, the Spanish Society of Pharmacists and Farmapericos, the Catalan Federation of Adapted Sports and Afrucat
IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day Read More »
Researchers from the transformation and metastasis group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Eva González-Suárez, have been able to recreate and characterize the process of acquisition of resistance to chemotherapy in orthotopic animal models of breast cancer, unveiling the possibility of reversing this resistance after a period of rest from the
